Carotid body tumor diagnostic study of choice

Jump to navigation Jump to search

Carotid body tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carotid Body Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carotid body tumor diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carotid body tumor diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carotid body tumor diagnostic study of choice

CDC on Carotid body tumor diagnostic study of choice

Carotid body tumor diagnostic study of choice in the news

Blogs on Carotid body tumor diagnostic study of choice

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Carotid body tumor diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

Diagnostic Study of Choice

  • The carotid body tumor is diagnosed primarily by history and physical examination.[1]
  • Imaging studies are necessary to make the final diagnosis.
  • Traditionally, digital subtraction angiography (DSA) has been the golden standard for the diagnosis of carotid body tumor.
  • However, DSA has been replaced by other imaging studies such as CT angiography and MR angiography which provides an accurate angiogram as well as information on the local extension of the tumor to the adjacent tissues.[2]
  • Color Doppler ultrasound has been recommended as a method of screening for the diagnosis of carotid body tumor.[3]
    • This method is useful in the diagnosis of Shamblin’s type and intralesional blood flow of the tumor before the metastasis.[2]
  • CT imaging is useful in the diagnosis of local invasion of the tumor to adjacent arteries and skull base.
    • This metthod is able to differentiate the tumor from other paragangliomas.[2]
  • CT imaging combined with color doppler ultrasound has been suggested as the optimal detection modality for the assessment and management of the tumor.
  • Since the tumor is highly vascular, incisional biopsy and percutaneous needle aspiration are contraindicated and it may cause complications such as:[4]
    • Massive bleeding
    • Pseudoaneurysm formation
    • Carotid thrombosis

The comparison of various diagnostic studies for carotid body tumor

Test Sensitivity Specificity Accuracy
CT angiography 100% 100% 100%
Color Doppler ultrasound 89.8% 82.6% 87.5%
  • It is also suggested that CT angiography is more accurate than color Doppler ultrasound for the diagnosis of larger lesions.[2]
  • Genetic analysis should be considered for patients with:[5]
    • A positive family history
    • Presence of multiple paragangliomas
    • Those who manifest the tumor before 50 years of age.
Sequence of Diagnostic Studies
  • The first line imaging modality for the diagnosis and assessment of the tumor is Color Doppler ultrasound.[2][6]
  • CT imaging can be used as the second line modality for the diagnosis of selected cases.[2]
    • Second line imaging modality is highly suggested in those with a positive family history and multifocal disease.

Name of Diagnostic Criteria

  • There are no established criteria for the diagnosis of carotid body tumor.

References

  1. Luo T, Zhang C, Ning YC, Gu YQ, Li JX, Wang ZG (March 2013). "Surgical treatment of carotid body tumor: case report and literature review". J Geriatr Cardiol. 10 (1): 116–8. doi:10.3969/j.issn.1671-5411.2013.01.018. PMC 3627704. PMID 23610583.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Jin, Zhan-Qiang; He, Wen; Wu, Dong-Fang; Lin, Mei-Ying; Jiang, Hua-Tang (2016). "Color Doppler Ultrasound in Diagnosis and Assessment of Carotid Body Tumors: Comparison with Computed Tomography Angiography". Ultrasound in Medicine & Biology. 42 (9): 2106–2113. doi:10.1016/j.ultrasmedbio.2016.04.007. ISSN 0301-5629.
  3. Worsey, M.J.; Laborde, A.L.; Bower, T.; Miller, E.; Kresowik, T.F.; Sharp, W.J.; Corson, J.D. (1992). "An Evaluation of Color Duplex Scanning in the Primary Diagnosis and Management of Carotid Body Tumors". Annals of Vascular Surgery. 6 (1): 90–94. doi:10.1007/BF02000675. ISSN 0890-5096.
  4. Mirov, Andrew G. (1962). "Benign and Malignant Carotid Body Tumors". JAMA: The Journal of the American Medical Association. 181 (1): 13. doi:10.1001/jama.1962.03050270015003. ISSN 0098-7484.
  5. Davila, Victor J.; Chang, James M.; Stone, William M.; Fowl, Richard J.; Bower, Thomas C.; Hinni, Michael L.; Money, Samuel R. (2016). "Current surgical management of carotid body tumors". Journal of Vascular Surgery. 64 (6): 1703–1710. doi:10.1016/j.jvs.2016.05.076. ISSN 0741-5214.
  6. Tong Y (August 2012). "Role of duplex ultrasound in the diagnosis and assessment of carotid body tumour: A literature review". Intractable Rare Dis Res. 1 (3): 129–33. doi:10.5582/irdr.v1.3.129. PMID 25343084.